SCHEMBL6825009

SCHEMBL6825009

CCNC(=O)Nc1cc(Br)ccc1Nc1ccc(C(=O)c2ccc(F)cc2C)c(Cl)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 9/20 0.64
MAPK12 P53778 9/20 0.64
MAPK11 Q15759 9/20 0.64
MAPK14 Q16539 9/20 0.64
MAPT P10636 4/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
ALDH1A1 P00352 2/20 0.40
TP53 P04637 1/20 0.38
EPHX2 P34913 1/20 0.38
EGFR P00533 1/20 0.38
ERBB2 P04626 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
AVPR2 P30518 1/20 0.37
OXTR P30559 1/20 0.37
AVPR1A P37288 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6826625 0.91 MAPK13 (0.66) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL6825252 0.90 MAPK13 (0.64) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL6824376 0.89 MAPK14 (0.81) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL6905610 0.88 MAPK13 (0.64) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL7647177 0.88 MAPK13 (0.62) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2199268 0.87 MAPK14 (0.81) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL6821134 0.86 MAPK13 (0.61) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL6824811 0.86 MAPK13 (0.65) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL6824668 0.86 MAPK13 (0.60) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL6824188 0.85 MAPK14 (0.69) MAPK13MAPK12MAPK11MAPK14MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1210325-B1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMA AS (DK) 2004-10-06 EP claimed
US-6750253-B1 INHIBITION OR DOWN REGULATION OF THE CYTOKINES IS POSSIBLY DUE TO AN INHIBITION OF MAP KINASES LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2004-06-15 US claimed
EP-1210325-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 2002-06-05 EP claimed
WO-2001005751-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) 2001-01-25 WO claimed
EP-1210325-B1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMA AS (DK) 2004-10-06 EP disclosed
US-6750253-B1 INHIBITION OR DOWN REGULATION OF THE CYTOKINES IS POSSIBLY DUE TO AN INHIBITION OF MAP KINASES LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2004-06-15 US disclosed
EP-1210325-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 2002-06-05 EP disclosed
WO-2001005751-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) 2001-01-25 WO disclosed